Effects of Electroacupuncture on Facial Nerve Function and HSV-1 DNA Quantity in HSV-1 Induced Facial Nerve Palsy Mice
Table 2
Detection of HSV-1 DNA during treatment period and at the end of treatment period ().
G
At day 3 of treatment period
At day 7 of treatment period
At day 14 of treatment period
Facial nerve (2−△△CT)
Geniculate ganglion (2−△△CT)
Brainstem (2−△△CT)
Cerebral cortex (2−△△CT)
Facial nerve (2−△△CT)
Geniculate ganglion (2−△△CT)
Brainstem (2−△△CT)
Cerebral cortex (2−△△CT)
Facial nerve (2−△△CT)
Geniculate ganglion (2−△△CT)
Brainstem (2−△△CT)
Cerebral cortex (2−△△CT)
A
10
0**
0**
0**
0**
0**
0**
0**
0**
0**
0**
0**
0**
B
10
0**
0**
0**
0**
0**
0**
0*
0**
0**
0**
0**
0**
C
10
13.67 ± 2.16
11.82 ± 1.81
7.73 ± 1.08
6.52 ± 2.27
15.42 ± 2.71
14.18 ± 1.97
12.57 ± 3.11
6.52 ± 2.27
9.89 ± 1.47
7.63 ± 1.22
6.77 ± 1.28
6.14 ± 1.63
D
10
9.84 ± 1.29*
9.04 ± 2.29*
3.04 ± 2.29*
2.17 ± 1.14*
2.18 ± 2.13**
1.78 ± 1.14**
1.04 ± 1.48**
2.17 ± 1.25**
0.71 ± 0.16**
0.18 ± 0.21**
0.03 ± 0.09**
0.05 ± 0.13**
The quantity of HSV-1 DNA was expressed with 2−ΔΔCT of difference ratio of HSV-1 mRNA. Group A: blank control group; Group B: saline group; Group C: model animal group; Group D: electroacupuncture group. *Compared with Group C, . **Compared with Group C, .
